Podcast Name
Markets
November 2025
110 minutes
The Biotech Rebuild: Finding Alpha After the Drawdown with Chris Clark | #606
The Meb Faber Show
Chris Clark explains biotech’s post-drawdown landscape, differences between venture and public investing, and how regulation and AI shape drug development.
Portfolio Management
December 2023
65 minutes
Financing Biotech: Portfolio Theory and Netflix-Inspired Models
The Bioverge Podcast
MIT Professor of Finance Andrew Lo discusses his application of portfolio theory to address the challenges of funding drug development. […]
Markets
December 2023
91 minutes
For Blood and Money
The Compound and Friends
Nathan Vardi joins the show to discuss his book, For Blood and Money, the biotech investment landscape today, and stories of top […]
Markets
August 2023
55 minutes
Here’s How the New Weight Loss Drugs Could Change Everything
Odd Lots
James van Geelen of Citrinitas Capital’s James van Geelen shares how he’s evaluating the potential of new weight loss medications, how […]
Global Macroeconomics
March 2023
39 minutes
American Optimism with Joe Lonsdale
Raising Health
Serial entrepreneur & investor Joe Lonsdale shares what led him to become a co-founder of Palantir & Addepar, what factors […]
Markets
December 2022
21 minutes
A Prescription For Healthcare Investing
MIT economist & professor Andrew Lo shares what led him to want to help the biotech field better finance breakthrough […]
Markets
August 2022
41 minutes
Solving prescription drug pricing in the US with Cost Plus Drugs & Capital RX CEOs
This Week in Startups
For the first 41 minutes, Alex Oshmyansky, CEO of The Mark Cuban Cost Plus Drug Company, shares the purpose of Cost Plus, […]
Markets
February 2022
31 minutes
20VC: Mark Cuban on Reshaping the Pharmaceuticals Industry, How To Hire and Build Truly Great Teams and What Brand Really Means Today and How To Build One Successfully
Mark Cuban discusses disrupting the pharmaceutical supply chain, fixing structural inefficiencies in healthcare, and how mission driven businesses can reshape […]
Markets
July 2021
32 minutes
Dr. Rick Klausner on the Biotech Revolution | Season 1 Ep 1
Dr. Rick Klausner discusses the biotech revolution, how COVID and gene editing are accelerating innovation, and why aging and cancer […]
Markets
December 2020
39 minutes
The Machine That Made the Vaccine
Moderna CEO Stephane Bancel discusses mRNA vaccine development, the platform behind rapid design, and implications for the future of drug […]